Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Logan, Brent R  [Clear All Filters]
Journal Article
Shaw, B.E., Logan, B.R., Kiefer, D.M., Chitphakdithai, P., Pedersen, T.L., Abdel-Azim, H., Abidi, M.H., Akpek, G., Diaz, M.A., Artz, A.S., et al. (2015). An Analysis of the Effect of Race, Socioeconomic Status and Center Size on Unrelated NMDP Donor Outcomes: Donor Toxicities are More Common at Low Volume Bone Marrow Collection Centers.Biol Blood Marrow Transplant.
Zinter, M.S., Logan, B.R., Fretham, C., Sapru, A., Abraham, A., Aljurf, M.D., Arnold, S.D., Artz, A., Auletta, J.J., Chhabra, S., et al. (2019). Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries.Biol Blood Marrow Transplant.
Prokopishyn, N.L., Logan, B.R., Kiefer, D.M., Sees, J.A., Chitphakdithai, P., Ahmed, I.A., Anderlini, P.N., Beitinjaneh, A.M., Bredeson, C., Cerny, J., et al. (2019). The concentration of total nucleated cells in harvested bone marrow for transplantation has decreased over time.Biol Blood Marrow Transplant.
Pulsipher, M.A., Logan, B.R., Chitphakdithai, P., Kiefer, D.M., Riches, M.L., J Rizzo, D., Anderlini, P., Leitman, S.F., Varni, J.W., Kobusingye, H., et al. (2018). The Effect of Aging and Pre-Donation Comorbidities on the Related PBSC Donor Experience: A Report from the Related Donor Safety Study (RDSafe).Biol Blood Marrow Transplant.
Pulsipher, M.A., Logan, B.R., Kiefer, D.M., Chitphakdithai, P., Riches, M.L., J Rizzo, D., Anderlini, P., Leitman, S.F., Varni, J.W., Kobusingye, H., et al. (2018). Higher risks of toxicity and incomplete recovery in 13-17 year old females after marrow donation: RDSafe peds results.Biol Blood Marrow Transplant.
Young, J.-A.H., Logan, B.R., Wu, J., Wingard, J.R., Weisdorf, D.J., Mudrick, C., Knust, K., Horowitz, M.M., Confer, D.L., Dubberke, E.R., et al. (2015). Infections following Transplantation of Bone Marrow or Peripheral-Blood Stem Cells from Unrelated Donors.Biol Blood Marrow Transplant.
Eapen, M., Logan, B.R., Appelbaum, F.R., Antin, J.H., Anasetti, C., Couriel, D.R., Chen, J., Maziarz, R.T., McCarthy, P.L., Nakamura, R., et al. (2014). Long-term Survival after Transplantation of Unrelated Donor Peripheral Blood or Bone Marrow Hematopoietic Cells for Hematologic Malignancy.Biol Blood Marrow Transplant.
Jacobsohn, D.A., Loken, M.R., Fei, M., Adams, A., Brodersen, L.Eidenschin, Logan, B.R., Ahn, K.Woo, Shaw, B.E., Kletzel, M., Olszewski, M., et al. (2018). Outcomes of measurable residual disease in pediatric acute myeloid leukemia pre- and post-hematopoietic stem cell transplant: validation of difference from normal flow cytometry with chimerism studies and Wilms tumor 1 gene expression.Biol Blood Marrow Transplant.
Armand, P., Kim, H.T., Logan, B.R., Wang, Z., Alyea, E.P., Kalaycio, M.E., Maziarz, R.T., Antin, J.H., Soiffer, R.J., Weisdorf, D.J., et al. (2014). Validation and refinement of the disease risk index for allogeneic stem cell transplantation: a study from the CIBMTR.Blood.